Periodontal Treatment Market to Reach US$ 12.2 Bn by 2031: TMR Study

04 Jan 2023
Acquisition
Rise in adoption of minimally invasive non-surgical procedures in the management of periodontitis in adults is likely to drive the global periodontal treatment market
Asia Pacific market is anticipated to witness substantial rise in revenue during the forecast period
WILMINGTON, Del., Jan. 4, 2023 /PRNewswire/ -- Increase in focus of people on oral health and high prevalence of periodontal diseases among the global population are likely to propel periodontal treatment market growth. Governments are offering funding for development of innovative medical devices in dentistry, which is likely to broaden periodontal treatment market outlook. The periodontal treatment market size stood at US$ 7.6 Bn in 2021.
Advancements in non-surgical periodontal therapy is set to present attractive opportunities to companies in the periodontal treatment market. Associated risk factors of periodontitis are sedentary lifestyle, unhealthy diet, and tobacco consumption. An understanding of these factors has helped healthcare providers decide the extent of the management required in various forms of periodontitis. High prevalence of chronic periodontitis in adults is expected to create attractive business opportunities for companies in the market.
Get Exclusive PDF Sample Copy of Periodontal Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85283
Key Findings of Study
Rise in Demand for Non-surgical Periodontal Therapies: Demand for non-surgical treatments for periodontal diseases has increased significantly in the past few years. The treatments include periodontal scaling & root planning and usage of antibiotics, especially in severe forms of periodontal disease. Advances in pharmacologic therapies are expected to create significant opportunities for companies in the market in the next few years.
Patient Preference for Dental Clinics: Dental clinics are the most preferred healthcare setting for the management of periodontal diseases. The segment held major share of the market in 2021. Patients suffering from oral health conditions prefer dental clinics to hospitals. Rise in prevalence of periodontal diseases among adults presents significant untapped opportunities for companies. Incidence of these disease is high in older adults (aged 65 years and above). Adoption of periodontal regeneration therapies has led to increased commercialization of advanced bone graft products, thus fueling market growth.
Key Drivers
Advancements in the treatment modalities for periodontitis, including adoption of advanced dental bone graft products, is a key driver of the periodontal treatment market. Companies are likely to record higher revenue due to increasing commercialization of bone graft substitutes.
Rise in awareness about oral health along with patient-specific risk factors of periodontal diseases is expected to propel market development. These risk factors include smoking and inadequate oral health practices. Furthermore, epidemiologic associations between diabetes mellitus and periodontal diseases presents untapped avenue for companies in the periodontal treatment industry. This is because patients with diabetes mellitus are at a greater risk of developing periodontal disease.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=85283
Regional Growth Dynamics
North America held major market share in 2021. Development of novel technologies and rise in R&D in advanced periodontal therapies have fueled market growth in the region in the past few years.
The market in Asia Pacific is likely to grow at a rapid pace from 2022 to 2031. High burden of periodontal diseases, especially in Southeast Asia, and rise in prevalence of oral diseases are expected to propel the market in the region.
Competition Landscape
The global periodontal treatment market in consolidated, with the presence of small number of leading players. These players are restructuring product portfolio and engaging in merger & acquisition in order to consolidate their positions in the market. Prominent companies in the periodontal treatment market are Planmeca Oy, Novartis AG, Medtronic, Karl Schumacher, Dentsply Sirona, Danaher, Carl Martin GmbH, Biolase, Inc., ASA Dental S.p.A, 3M, and Amyndas Pharmaceuticals.
Periodontal Treatment Market Segmentation
Treatment Type
Non-surgical Treatment
Scaling & Root Planning
Antibiotics
Systemic Antibiotics
Local Antibiotics
Surgical Treatment
Pocket Reduction Surgery
Soft Tissue Grafts
Bone Grafts
Others
End-user
Hospitals
Dental Clinics
Others
Regions Covered
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Countries Covered
U.S.
Canada
Germany
U.K.
France
Spain
Italy
Japan
China
India
ASEAN
Brazil
Mexico
GCC Countries
Buy this Premium Research Report | Immediate Delivery Available – https://www.transparencymarketresearch.com/checkout.php?rep_id=85283&ltype=S
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Oral Thin Films Market
Consumer Genomics Market
Acute Migraine Treatment Market
Dental Anesthetics Market
Ceftriaxone Market
Fusion Inhibitors Market
Anti-radiation Drugs Market
Asthma Treatment Market
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Nikhil Sawlani
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.